A new analysis has found that adult trials outnumber trials for children by 11 to 1.
Connecting families to music therapy, with Jenna Marcovitz, MA
Music therapist Jenna Marcovitz discusses the role of pediatricians in making timely referrals to music therapy to support whole-child health.
Food Insecurity and the Dangers of Infant Formula Dilution
Phase 3 data show effectiveness of somapacitan in children with growth disorders
Somapacitan was non-inferior and had a similar safety profile and clinical outcomes compared to once-daily somatropin in improving yearly growth rates.
Demystifying Infant Formula
INZ-701 shows early promise in treating ENPP1 Deficiency in pediatric patients
Safety, phosphate level gains, and immunogenicity data offer encouraging signals in the pivotal trial.
FDA accepts NDA for berotralstat in HAE patients aged 2 to 11 years
The federal agency provided BioCryst Pharmaceuticals a target action date of September 12, 2025 for potential approval of berotralstat (ORLADEYO).
